Vimarsana
Biggest News Aggregation in the World

Peter Tak News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Tak. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Tak Today - Breaking & Trending Today

Classical: PianoArts Festival Features Rising Stars - Vimarsana News

Classical: PianoArts Festival Features Rising Stars

Young competition winners and skilled veterans perform in North American event.

GSK's New Vaccine Kept the Boss in Her Job — and an Activist at Bay - Vimarsana News

GSK's New Vaccine Kept the Boss in Her Job — and an Activist at Bay

(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer of GSK Plc found her remedy in a product almost 60 years in the making.Most Read from BloombergHims Debuts $199 Weight-Loss Shots at 85% Discount to WegovyIran State TV Says ‘No Sign of Life’ at Helicopter Crash SiteJamie Dimon Says Succession at JPMorgan Is ‘Well on the Way’One of the Last Big Bears on Wall Street Turns Bullish on US StocksFlorida’s 125% Surge in Property-

Source: yahoo.com
CAN-2409 Receives FDA Orphan Drug Designation in Pancreatic Cancer - Vimarsana News

CAN-2409 Receives FDA Orphan Drug Designation in Pancreatic Cancer

CAN-2409 has received orphan drug designation from the FDA for the treatment of patients with pancreatic cancer.

CAN-2409 Plus Valacyclovir Generates Positive Phase 2 Survival Results in PDAC - Vimarsana News

CAN-2409 Plus Valacyclovir Generates Positive Phase 2 Survival Results in PDAC

Positive phase 2 findings for CAN-2409 plus valacyclovir in pancreatic ductal adenocarcinoma have been reported.

FDA Grants Fast Track Designation to CAN-3110 for Recurrent High-Grade Glioma - Vimarsana News

FDA Grants Fast Track Designation to CAN-3110 for Recurrent High-Grade Glioma

CAN-3110, an HSV-1 oncolytic viral immunotherapy candidate, has received FDA fast track designation for adult patients with recurrent high-grade glioma.